| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/04/2009 | WO2009007326A3 Method for the production of an aqueous glucose solution from corn |
| 06/04/2009 | WO2008045346A3 Recombinant modified vaccinia ankara encoding a her-2 antigen for use in treating cancer |
| 06/04/2009 | WO2008022963A3 Isolation and characterization of a novel pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains |
| 06/04/2009 | WO2007018585A3 Process for controlling protein to salt ratio in animal muscle protein composition and protein composition |
| 06/04/2009 | WO2006012586A3 Modulation of fiaf and the gastrointestinal microbiota |
| 06/04/2009 | WO2005017099A3 Metabolically engineered bacterial strains having non-functional endogenous gluconate transporters |
| 06/04/2009 | WO2001079222A3 Haplotypes of the mc4r gene |
| 06/04/2009 | WO2001055301A3 Nucleic acids, proteins, and antibodies |
| 06/04/2009 | US20090144859 GTP Binding Stress-Related Proteins and Methods of Use in Plants |
| 06/04/2009 | US20090144857 Receptors for hypersensitive response elicitors and uses thereof |
| 06/04/2009 | US20090144854 Novel Bacterial Proteins with Pesticidal Activity |
| 06/04/2009 | US20090144852 Axmi-066 and axmi-076: delta-endotoxin proteins and methods for their use |
| 06/04/2009 | US20090144850 Generation of plants with improved drought tolerance |
| 06/04/2009 | US20090144849 Nucleic acid molecules and other molecules associated with transcription in plants |
| 06/04/2009 | US20090143997 Methods and compositions for cancer treatment relating to BRCA1 BRCT domain recognition of phosphorylated BACH1 |
| 06/04/2009 | US20090143571 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 06/04/2009 | US20090143568 Recombinant gelatins |
| 06/04/2009 | US20090143567 Multiblock copolymers having improved mechanical properties |
| 06/04/2009 | US20090143309 converting an agonist of protein kinase C to an antagonist of protein kinase C; amino acid sequences; crosslinked via an N-terminal Cys-Cys bond to a peptide to facilitate transport cellular uptake |
| 06/04/2009 | US20090143308 Yeast membrane protein expression system and its application in drug screening |
| 06/04/2009 | US20090143298 Broad-Spectrum Delta-Endotoxins and Method and Kit for Detecting Same and for Detecting Polynucleotides Encoding Same |
| 06/04/2009 | US20090143297 Modulators of antiestrogen pharmacology |
| 06/04/2009 | US20090143293 Peptide inhibitors of protein kinase C gamma for pain management |
| 06/04/2009 | US20090143291 Tumor antigen based on products of the tumor suppressor gene wt1 |
| 06/04/2009 | US20090143290 Tumor-inhibiting protein and the use thereof |
| 06/04/2009 | US20090143289 Orthopoxvirus vectors, genes and products thereof |
| 06/04/2009 | US20090143288 Peptide-complement conjugates |
| 06/04/2009 | US20090143283 Pituitary Adenylate Cyclase Activating Peptide (PACAP) Receptor (VPAC2) Agonists and Their Pharmacological Methods of Use |
| 06/04/2009 | US20090143278 Process for preparing bioactive protein-enriched whey products |
| 06/04/2009 | US20090142855 Polynucleotides and Polypeptides of the IL-12 Family of Cytokines |
| 06/04/2009 | US20090142840 DNA encoding anti-apoptotic protein and recombinant 30K protein |
| 06/04/2009 | US20090142828 eukaryotic cell comprising an inducible transcription regulator element; for enhancing translation in cells via switching cells from replicative to productive state, followed by protein isolation after generation of pseudo-senescent state |
| 06/04/2009 | US20090142822 Crystal Structure of an Angiotensin-Converting Enzyme (ACE) and Uses Thereof |
| 06/04/2009 | US20090142815 Gene SMS 05 |
| 06/04/2009 | US20090142806 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor |
| 06/04/2009 | US20090142802 Polypeptides and nucleic acids encoding same |
| 06/04/2009 | US20090142801 butyrophilin-like nucleic acids; for diagnosis and treatment of inflammatory bowel diseases and for enhancing a mucosal immune response to an antigen |
| 06/04/2009 | US20090142800 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/04/2009 | US20090142794 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 06/04/2009 | US20090142786 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/04/2009 | US20090142784 Methods |
| 06/04/2009 | US20090142783 Human p51 Genes and Gene Products Thereof |
| 06/04/2009 | US20090142782 Using actinobacillus specific immunogolbulins to diagnose gum disease |
| 06/04/2009 | US20090142778 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease |
| 06/04/2009 | US20090142777 Reagents for the detection of protein phosphorylation in leukemia signaling pathways |
| 06/04/2009 | US20090142754 RNA Detection Assays |
| 06/04/2009 | US20090142746 Pancreatic Cancer Genes |
| 06/04/2009 | US20090142397 Reduction of dermal scarring |
| 06/04/2009 | US20090142376 Chlamydia polypeptides and corresponding dna fragments and uses thereof |
| 06/04/2009 | US20090142373 Immunizing Against HIV Infection |
| 06/04/2009 | US20090142359 Anti-Her2 antibodies which induce apoptosis in Her2 expressing cells; treating cancer by Her2 overexpression using the antibodies |
| 06/04/2009 | US20090142353 Human Tumor Necrosis Factor Receptor TR17 |
| 06/04/2009 | US20090142351 Human and rat PGC-3, PPAR-gamma coactivations and splice variants thereof |
| 06/04/2009 | US20090142350 Pancreatic Cancer Genes |
| 06/04/2009 | US20090142341 Mutated pseudomonas exotoxins with reduced antigenicity |
| 06/04/2009 | US20090142334 DETECTION AND MODULATION OF IAPs AND NAIP FOR THE DIAGNOSIS AND TREATMENT OF PROLIFERATIVE DISEASE |
| 06/04/2009 | US20090142332 Identification of Biomarkers by Serum Protein Profiling |
| 06/04/2009 | US20090142329 Interleukin-1 Beta Converting Enzyme Like Apoptosis Protease-3 and 4 |
| 06/04/2009 | US20090142300 Compositions and methods related to toll-like receptor-3 |
| 06/04/2009 | US20090142294 Parameter selected gm-csf, il-3, il-4, il-5 and chimeras thereof for therapeutic and diagnostic purposes |
| 06/04/2009 | US20090142283 Peptide-based antidandruff reagents |
| 06/04/2009 | US20090142262 Method of Diagnosing, Monitoring, Staging, Imaging and Treating Prostate Cancer |
| 06/04/2009 | CA2707190A1 Novel wheat allergens |
| 06/04/2009 | CA2706835A1 Stat3 epitope peptides |
| 06/04/2009 | CA2706799A1 Transgenic plants with increased stress tolerance and yield |
| 06/04/2009 | CA2706603A1 Method for producing vaccinal viral strain of a virus of the reoviridae family |
| 06/04/2009 | CA2706602A1 Plants having enhanced yield-related traits and a method for making the same |
| 06/04/2009 | CA2706600A1 Novel polypeptides having endolysin activity and uses thereof |
| 06/04/2009 | CA2700823A1 Novel bank1 splice variant |
| 06/03/2009 | EP2065468A1 Modifications of hiv env enhance immunogenicity for genetic immunization |
| 06/03/2009 | EP2065402A1 Trimeric collagen scaffold antibodies |
| 06/03/2009 | EP2065397A1 Method for the separation of cells |
| 06/03/2009 | EP2065396A1 Interleukin-19 |
| 06/03/2009 | EP2065395A1 Gene expression associated with osteoblast differentiation |
| 06/03/2009 | EP2065394A1 Peptide for determining actin structures in living cells |
| 06/03/2009 | EP2065393A1 Infectious cDNA of an approved vaccine strain of measles virus. Use for immunogenic compositions |
| 06/03/2009 | EP2065392A2 Fusion antigen uses as vaccine |
| 06/03/2009 | EP2065052A2 Anti-IgE vaccines |
| 06/03/2009 | EP2065050A1 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 06/03/2009 | EP2065037A1 Means and methods for treating or preventing brain tumors based on the nuclear receptor tailless (Tlx) |
| 06/03/2009 | EP2064943A2 Plants with improved morphogenesis and method of constructing the same |
| 06/03/2009 | EP2064550A2 Prrg4-associated compositions and methods of use thereof in methods of tumor diagnosis |
| 06/03/2009 | EP2064330A2 Plants with increased tolerance and/or resistance to environmental stress and increased biomass production |
| 06/03/2009 | EP2064245A1 Methods for blocking the interaction between nkp80 and its ligand aicl |
| 06/03/2009 | EP2064238A1 Crystal structure of the thsr receptor |
| 06/03/2009 | EP2064237A2 Il-17c antagonists and methods of using the same |
| 06/03/2009 | EP2064236A2 Method for improving the specific effector function of single-chain antigen-recognizing genetic constructs (scarc) through murinization thereof |
| 06/03/2009 | EP2064235A1 The death receptor cd95 controls neurogenesis of adult neural stem cells in vivo and in vitro |
| 06/03/2009 | EP2064234A2 Bioactive peptides and method of using same |
| 06/03/2009 | EP2064233A1 Method of increasing resistance against soybean rust in transgenic plants |
| 06/03/2009 | EP2064232A2 Immunostimulatory composition comprising lipoprotein in microalgae extract |
| 06/03/2009 | EP2064231A1 Immunoreactive glycoprotein gp19 of ehrlichia canis |
| 06/03/2009 | EP2064230A2 Immunogens from uropathogenic escherichia coli |
| 06/03/2009 | EP2064226A2 Novel haplotype of human t2r receptor ht2r50 and its use in assays for identifying human bitter taste modulators |
| 06/03/2009 | EP2063911A2 Immunogenic compositions for gram positive bacteria |
| 06/03/2009 | EP2063908A2 Use of modified interleukin-8 proteins for treating reperfusion injury or transplant rejection |
| 06/03/2009 | EP2063905A2 Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates |
| 06/03/2009 | EP1945657A4 Tlr3 glycosylation site muteins and methods of use |
| 06/03/2009 | EP1781328A4 Methods for discovering antibodies specific to cancer cells and antibodies discovered thereby |
| 06/03/2009 | EP1779116B1 A method of diagnosing tuberculosis |